Asthma
COPD
Pulmonary
Search: Page 20
Article
Blog
Company
Podcast
Product
Video
Whitepaper
Enter search phrase
Search
657 Results
Type: Article
Pulmonary
Could bioelectronic medicine be the answer to curing PAH?
A research team at the Feinstein Institutes provides promising results.
June 5, 2024
Asthma
Repressing signs and symptoms of allergic asthma
Engineered CAR T cells show promise in mice model.
June 5, 2024
Asthma
High sugar intake may reduce onset of childhood asthma
Inversely, dietary fat, magnesium and vitamin D could increase one's risk.
June 5, 2024
COPD
FDA delays priority review of Dupixent by three months
A decision on the potential COPD treatment has been pushed back to September 2024.
June 5, 2024
COPD
Study unveils safe beta-blocker solution for COPD patients
Results presented at ATS 2024 show that bisoprolol can be prescribed to patients with COPD for cardiac disease treatment.
June 5, 2024
Pulmonary
ATS session presents potential discovery for women with PH
Research suggests likely association between hormone replacement therapy and pulmonary hypertension.
May 31, 2024
Pulmonary
Hopeful IPF drug falls short in latest trial
Pamrevlumab performs in early phases but fails to slow progression in long term.
May 31, 2024
Asthma
Oral rilzabrutinib clinical trial helps patients achieve asthma control
Sanofi presented the late-breaking data, which demonstrate primary and secondary endpoints, at ATS 2024.
May 31, 2024
Asthma
New drug aimed at dual treatment of asthma and hair loss from cancer
Perseus Therapeutics announces plans to develop TSLP antibody.
May 31, 2024
COPD
ATS 2024: ASLAN presents data on eblasakimab
Transitional data was presented on a head-to-head study of eblasakimab and dupilumab in a human tissue model.
May 30, 2024
COPD
Fasenra could have potential for COPD
The FDA-approved asthma medication is currently in trials for additional uses.
May 30, 2024
Asthma
Severe asthma: Then and now
ATS Conference Scientific Symposium explored the road to new severe asthma therapies.
May 28, 2024
Asthma
High marks for GSK’s depemokimab phase 3 SWIFT-1 and SWIFT-2 trials
New drug could be effective treatment for treating severe asthma.
May 28, 2024
Pulmonary
Revolutionizing imaging software to help save lives
Scientists develop better diagnostic solution for patients with lung conditions who can’t endure contrast dye.
May 28, 2024
Pulmonary
Imdelltra receives FDA accelerated approval
Novel therapy will treat adult patients with extensive-stage small cell lung cancer.
May 28, 2024
COPD
ATS 2024: Study takes race out of the equation
Spirometry clinical trial eligibility may differ with race-neutral equations.
May 23, 2024
COPD
Tezspire shows promising potential for COPD treatment
Results from the phase 2a COURSE trial provide insight into the impact on COPD exacerbations.
May 23, 2024
COPD
Start-up aims to develop drugs for immunology and inflammation
Three hundred million in financing will go toward clinical trials for COPD and asthma treatments.
May 17, 2024
Previous Page
Page 20 of 37
Next Page